A randomized evaluation of betrixaban, an oral factor Xa inhibitor, for prevention of thromboembolic events after total knee replacement (EXPERT)

Alexander G G Turpie, Kenneth A. Bauer, Bruce L. Davidson, William D. Fisher, Michael Gent, Michael H. Huo, Uma Sinha, Daniel D. Gretler